Biomarker test to optimise statin treatment worth its cost? Clinical study 25 February 2013 Pages: 7 - 7
Ranibizumab cost effective for common cause of vision loss Clinical study 25 February 2013 Pages: 9 - 9
Prostate cancer: abiraterone acetate beats cabazitaxel Clinical study 25 February 2013 Pages: 10 - 10
Selective lymphadenectomy not superior in endometrial cancer Clinical study 25 February 2013 Pages: 10 - 10
Personalised prostate cancer screening could save £ millions Clinical study 25 February 2013 Pages: 11 - 11
Pre-exposure prophylaxis for HIV may be cost effective Clinical study 25 February 2013 Pages: 11 - 11
Rotavirus vaccination economically attractive in Canada Clinical study 25 February 2013 Pages: 11 - 11
Renal denervation a good option in resistant hypertension Clinical study 25 February 2013 Pages: 12 - 12
Universal hep A vaccination real value for money in Brazil Clinical study 25 February 2013 Pages: 12 - 12
Cipla cuts price of erlotinib, docetaxel and capecitabine in India Media release 25 February 2013 Pages: 15 - 15
Combination prostate cancer therapies too costly for payers Media release 25 February 2013 Pages: 15 - 15
Post- and antenatal depression costs Australia $433 million Media release 25 February 2013 Pages: 15 - 15
Telaprevir now funded in majority of Canadian provinces Media release 25 February 2013 Pages: 15 - 15